Evidence Building
September 2023: Documenting patents for O-1
Expert analysis of recent developments and their impact on O-1 petitioners. Key takeaways inside.
How patents satisfy the original contribution criterion for O-1A
The original contribution criterion at 8 C.F.R. § 214.2(o)(3)(iii)(E) requires evidence of original scientific, scholarly, or business-related contributions of major significance in the field. Patents are among the most direct forms of evidence for this criterion because they represent a formal governmental determination that a claimed invention is novel, non-obvious, and useful—a three-part standard applied by trained patent examiners with domain expertise in the relevant technology area. An issued patent demonstrates not just that the inventor claimed novelty but that a technically qualified reviewer evaluated the claim against the prior art and found it to satisfy the statutory requirements under 35 U.S.C. § 102 and § 103.
For O-1A purposes, a patent's evidentiary value depends on both the fact of issuance and the significance of the patented innovation within the field. A patent covering a narrowly applicable engineering solution in a niche market carries less weight than a patent covering a fundamental technique that has been widely adopted in the industry. USCIS adjudicators are not patent examiners and will not independently assess the technical significance of the claimed invention; instead, they rely on expert letters from qualified professionals who can explain what the patented innovation represents in the context of the field, why it is significant relative to prior approaches, and what its impact on industry practice or scientific research has been.
Patent evidence is most persuasive when accompanied by secondary evidence of the patent's impact: citations of the patent by other patents or published research, licensing agreements that demonstrate commercial recognition of the invention's value, adoption of the patented technique by companies or research groups that are not affiliated with the original inventor, or recognition of the invention by industry bodies or awards programs. These secondary indicators transform the patent from a formal credential into evidence of field-level significance—the distinction between having an idea that USCIS found non-obvious and having an idea that the field has recognized as a meaningful contribution to advancing knowledge or practice.
Types of patent evidence USCIS evaluates in O-1A petitions
Several distinct types of patent-related evidence are relevant to O-1A petitions, and each serves a different evidentiary function. Issued patents from the USPTO, EPO, or equivalent national patent offices provide the foundational documentation: the patent number, filing and issue dates, inventor names, assignee (typically an employer), claim language, and abstract. These records are publicly available through the USPTO Patent Full-Text Database, Google Patents, or the European Patent Register and can be submitted as primary exhibit documents. The petition should identify which patents most directly demonstrate the beneficiary's original contribution and explain why those specific patents are significant.
International patent filings under the Patent Cooperation Treaty (PCT) provide evidence of a different type: they demonstrate that the innovation was considered significant enough to protect in multiple jurisdictions, which implies commercial or scientific value across markets. A PCT filing with subsequent national phase entry in multiple countries—particularly major technology markets such as the US, EU, Japan, South Korea, and China—suggests that the assignee or inventor assessed the innovation as having global commercial or strategic significance. Continuation patents, continuation-in-part patents, and divisional patents in a patent family can collectively document a sustained program of innovation in a particular technology area.
Patent citations—instances where other patents or published research papers have cited the beneficiary's patents—provide the strongest secondary evidence of a patent's field-level significance. Forward citations (citations of the beneficiary's patent by later patents or publications) can be retrieved from the USPTO Patent Full-Text Database using the patent's number as a search parameter, or from commercial patent databases such as Derwent Innovation, PatSnap, or Lens.org. A patent with a substantial number of forward citations from patents assigned to major companies or research institutions demonstrates that the field has built on the beneficiary's innovation—which is precisely the kind of impact that distinguishes an original contribution of major significance from a routine technical advance.
Issued patents versus pending applications: what USCIS credits
USCIS generally gives greater weight to issued patents than to pending applications because issued patents have completed the substantive examination process and represent a formal determination of novelty and non-obviousness. A pending application represents a claim that has been filed but not yet examined or allowed—it is not yet a legal determination of inventive merit, and it may be rejected, substantially amended, or abandoned during prosecution. For O-1A petitions, pending applications can be mentioned as evidence of ongoing innovative activity, but they should not be presented as equivalent to issued patents because the examination outcome is unknown.
Provisional patent applications, which are filed to establish a priority date without beginning the examination process, are even less useful as primary evidence for the original contribution criterion. Provisional applications are not examined, are not published, and expire after 12 months if not converted to a non-provisional application. Including a provisional application in an O-1 petition as evidence of a contribution can actually weaken the petition if USCIS adjudicators recognize that provisional applications do not represent a finding of novelty or non-obviousness by a patent examiner.
When a petition must be filed before relevant patent applications have been issued—because the beneficiary's employment needs to begin before the examination process completes—the petition should rely more heavily on expert letters to establish the significance of the underlying innovations. An expert letter from a recognized authority in the relevant technology area who can assess the claimed innovations based on their technical knowledge and characterize them as significant contributions—even without a patent office determination—provides credible evidence that the innovations meet the original contribution standard, even if the patent examination is still pending. The expert's credentials and the specificity of their technical assessment are what USCIS will evaluate.
Using patent citations as secondary evidence of field-level impact
Patent citation analysis is a well-established methodology in innovation research and patent valuation, and the results of citation analysis can be presented in O-1A petitions as evidence that the beneficiary's patents have influenced subsequent innovation in the field. The basic methodology involves searching for patents that cite the beneficiary's patents and then analyzing the citing patents by assignee, technology area, and temporal distribution. A patent that has been cited by patents assigned to major companies like Google, Microsoft, Apple, Qualcomm, or equivalent industry leaders in the relevant technology area demonstrates that those companies' engineers were aware of the beneficiary's innovation and found it relevant to their own subsequent work.
Citation counts for patents are not directly comparable to citation counts for academic publications because patent citation practices differ substantially by technology area and by company. Some technology sectors—particularly telecommunications and semiconductors—produce patents with high citation counts because the technology areas have large patent ecosystems with many practitioners who frequently cite prior art. Other sectors—particularly industrial manufacturing, materials science, and niche engineering specialties—produce patents with lower citation counts that nonetheless represent highly significant innovations within smaller practitioner communities. Expert letters should explain how the beneficiary's patent citation profile compares to that of other significant innovators in the same technology area, using specific comparisons to establish what the citation data means in context.
Cross-citations between patents and academic publications provide particularly rich evidence when they are available. When a peer-reviewed paper cites a patent as a foundational technical reference, or when a patent cites a published research paper by the beneficiary as prior art, the connection demonstrates that the beneficiary's work has moved between the academic research community and the practical innovation community in ways that reflect broad field influence. A beneficiary whose published papers are cited by both academic researchers and patent applications, and whose patents are cited by both later patents and academic publications, has a record that demonstrates extraordinary ability in terms of cross-domain field impact—a strong narrative for the O-1A cover letter.
Expert letters that contextualize patent evidence
Expert letters for patent evidence in O-1A petitions serve two primary functions: establishing the letter writer's qualifications to assess the significance of the patented innovations, and providing a specific, credible assessment of what the patents contribute to the field. The most persuasive expert letters for patent evidence come from recognized authorities in the specific technology area—senior engineers at companies that practice the relevant technology, academic researchers who publish in the field and are familiar with the prior art landscape, or patent practitioners who have specialized expertise in the technology area and can assess the patents' technical novelty relative to the prior art.
A credible expert letter about patent significance should address specific claims: what technical problem the patents solve, what the prior art approaches were before the beneficiary's innovation, how the beneficiary's approach differs from and improves upon prior approaches, and what the practical or scientific impact of the innovation has been. Generic statements to the effect that the beneficiary's patents are significant and represent important contributions are less persuasive than letters that engage with specific technical details—even at a level of detail that non-specialist USCIS adjudicators will not fully understand—because the technical specificity signals that the letter writer has actual knowledge of the technology and is making a substantive assessment rather than providing a courtesy endorsement.
Expert letters from patent practitioners—registered patent attorneys or agents with domain expertise in the technology area—are a sometimes-overlooked resource. A patent attorney who has prosecuted patents in the same technology area as the beneficiary's patents can provide an expert assessment of the patents' novelty and non-obviousness relative to the prior art based on their professional experience with what patent examiners have accepted and rejected in that area. This is a technically credible form of expert assessment that supplements letters from academic researchers and industry engineers, and it brings a formal professional credential (registration to practice before the USPTO) that USCIS can evaluate as a marker of the letter writer's qualifications.
Building a complete patent evidence package for O-1A filing
A complete patent evidence package for an O-1A petition should include: copies of the issued patents (full text or at minimum the front page with claims and abstract), documentation of the patent family (related patents in the same technology area), forward citation analysis showing subsequent patents and publications that have cited the beneficiary's patents, any licensing agreements or commercial adoption evidence that can be disclosed without violating confidentiality obligations, and two to three expert letters from qualified professionals who can assess the patents' technical significance and field-level impact. This package should be organized as a coherent exhibit rather than a pile of documents, with a cover letter narrative that explains how the elements connect to support the original contribution criterion.
Patents that are subject to employer assignment, as is the case for most patents generated by employees working in their ordinary job duties, present a nuance that the petition cover letter should address: the beneficiary invented the claimed technology even though the patent rights are owned by the employer. USCIS evaluates the original contribution criterion based on the beneficiary's inventive contribution, not on who owns the resulting intellectual property. The petition should be clear that the beneficiary is identified as an inventor on the patent (as shown on the patent document itself), that the beneficiary's role as inventor reflects their original creative and technical work, and that the employer's ownership of the assigned patent rights is a standard contractual arrangement that does not diminish the significance of the beneficiary's contribution.
For beneficiaries with large patent portfolios—particularly those who have worked in technology-intensive industries for many years—the petition should focus on the most significant patents rather than listing all patents as equivalent evidence. A petition that highlights three to five patents with specific evidence of their impact (citation data, licensing revenue, industry adoption) and strong expert letters about their significance is more persuasive than a petition that lists fifty patents without specific impact evidence for any of them. The goal is to demonstrate that the beneficiary's contributions are of major significance, not merely that the beneficiary has been prolific—and major significance requires specific evidence of impact, not just a count of formal credentials.